Us Congress Senate Bill SR757

Us Congress 2023-2024 Regular Session

• Introduced: 7/9/24

Caption

A resolution designating the week of May 5, 2024, through May 11, 2024, as "Tardive Dyskinesia Awareness Week".

Impact

The resolution encourages the public and healthcare professionals to be more vigilant in recognizing symptoms associated with TD. It supports ongoing monitoring of individuals on dopamine receptor blocking agents, which is crucial for the proper management of the disorder. By designating an official awareness week, the resolution serves to highlight the impacts of TD not only on those personally affected but also on their families and the healthcare system as a whole.

Summary

SR757 is a resolution designating the week of May 5, 2024, through May 11, 2024, as 'Tardive Dyskinesia Awareness Week'. The resolution aims to raise awareness about Tardive Dyskinesia (TD), a movement disorder that can occur as a side effect of prolonged use of certain medications, particularly antipsychotics and antiemetics used to treat various mental and gastrointestinal disorders. It emphasizes the importance of awareness, diagnosis, and treatment of TD, which affects approximately 600,000 individuals in the United States, yet is significantly underdiagnosed.

Contention

While the resolution is largely symbolic and seeks to promote awareness for an often overlooked condition, one point of contention might arise surrounding the resource allocation for raising awareness compared to other health priorities. There may also be discussion about the effectiveness of awareness campaigns and whether they lead to significant improvements in diagnosis and treatment practices in the healthcare community. Critics might question if such initiatives adequately address the complexities of mental health treatment or the broader systemic issues faced by individuals requiring such medications.